FDA OK's Diabetic Neuropathy Capsaicin Patch; EDCs Still a Threat

(MedPage Today) -- The FDA approved an 8% capsaicin patch (Qutenza) for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults, Grünenthal and Averitas Pharma announced.
During the pandemic...